In grade IV tumors, WT1 score was significantly higher in older age patients, a finding that has been confirmed previously (Rauscher et al., 2014), providing a link between WT1 expression and poor prognosis in glioblastomas and gliosarcomas. This evidence concerns the gene WT1 and glioblastoma.